On Thursday, in a statement GlaxoSmithKline said, it has agreed to sell 100% of stake in Unilever’s Indian business for nearly $3.35 billion (around 254.8 billion rupees) on the open market.

The development marks the British multinational pharmaceutical company cashing in late from the sale of the Horlicks brand.

Categories: Creativity, Entrepreneurship, HR & Organization, Strategy

Tags: British, GlaxoSmithKline, Horlicks brand, Indian business, multinational, open market, pharmaceutical, sale, sell, stake, Unilever